Anthony Balda
anthony.balda.wg12@
wharton.upenn.edu Cornell University, Ithaca NY B.S., Magna Cum Laude, Applied Economics and Management with Marketing Concentration, 2004
Jamil M. Beg
jamil.beg.wg12@
wharton.upenn.edu University of Pennsylvania, Philadelphia, PA Masters in Biotechnology, 2005 B.S.E., Bioengineering, 2004
Deepshikha Charan
deepshikha.charan.wg12@
wharton.upenn.edu University of Pennsylvania, Philadelphia, PA B.A., Summa Cum Laude, Biology, 2007 Perelman School of Medicine at the University of Pennsylvania M.D. Candidate, 2012
A leadership opportunity in an entrepreneurial healthcare organization.
Medtronic CardioVascular, Minneapolis, MN MBA Summer Associate – CoreValve Downstream Marketing, Summer 2011 Led team to develop international launch plan for new CoreValve Tran- scatheter Aortic Valve implant. Helped management develop a new brand strategy focused on CoreValve portfo- lio while leveraging Medtronic’s brand equity. Analyzed internal structures and recommended CRM software solution to manage key opinion leaders across multiple business units and countries.
Medicomp, Inc., Melbourne, FL Vice President, Marketing and Strategic Development, 2008-2010 Led initiatives for large partnership contracts, joint ventures and clinical trials. Negotiated exclusive contracts, including the largest Atrial Fibrillation clinical trial involving 3000 patients across 125 global centers. Researched and developed detailed plans for multiple new products including iPhone cardiac applications. Spear- headed commercialization of innova- tive new wireless cardiac telemetry device integrated with cellular technology.
Medicomp, Inc., Melbourne, FL Director of Marketing, 2004-2008 Management responsibility for marketing, PR, advertising, customer service and manufacturing. Achieved 20% year-on-year annual revenue growth. Executed 3 successful diagnostic ECG product launches. Developed innovative new marketing campaigns to combat decreasing insurance reimbursement.
An opportunity to apply my business and scientific expertise to challenging issues in the biopharma industry to grow a business while addressing serious unmet clinical needs.
Genentech, South San Francisco, CA Business Development Intern, Summer 2011 Managed the evaluation of ocular delivery technologies for marketed and development stage products. Led an R&D team to develop a research plan assessing the feasibility of an ocular delivery technology. Structured, negotiated, and closed a feasibility assessment agreement with an ocular delivery startup.
NuPathe Inc., Conshohocken, PA Business Development and Commercial Operations Manager, 2009-2010 (60% of time) Created a launch plan for the company’s lead product and built dynamic financial model for strategic planning, business development, and IPO underwriting.
TetraLogic Pharmaceuticals, Inc., Malvern, PA Business Development Manager, 2009-2010 (40% of time) Created an R&D plan for a novel drug from discovery through clinical proof of concept including preclinical and clinical trial planning, financial fore- casting, and commercial opportunity assessment.
Quaker BioVentures, LLC, Philadelphia, PA Analyst, 2007-2009 Contributed to 4 new and 8 follow-on investments representing ~$470M of syndicate capital. Managed diligence, negotiations, and deal execution for seed to late stage investments across the life science industry.
To use my business and medical knowledge to improve delivery of care to underserved populations both domestically and abroad.
McKinsey & Company, Chicago, IL Summer Associate, Summer 2011 Worked with an academic medical center to understand the effects of healthcare reform on hospitals. Specifically, analyzed the consequences of Medicare wage reformulations, healthcare exchanges, and account- able care organizations on health systems. Created a long-term strategic plan to ensure financial and clinical success for the health system.
University of Pennsylvania, Philadelphia, PA Research Assistant, 2011-present Analyzed the discharge planning process and studied the effect of novel patient education tools in reducing the rate of hospital readmissions. Patient literacy has been shown to have an effect on compliance with discharge instructions, which provides a lever to reduce readmissions in an environment where Medicare reimbursement for hospital readmissions will decrease.
Homeless Health Initiative, Philadelphia, PA Student Co-Chair, 2007-2009 Coordinated visits to a free pediatric clinic for homeless children. Implemen - ted peer mentorship model to increase the number of children seen during each visit.
7
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40